Refractory hypertension and sleep apnoea: Effect of CPAP on blood pressure and baroreflex

European Respiratory Journal

Volumn 21, Issue 2, 2003, Pages 241-247

  Logan, A G ^a   Tkacova, R ^b   Perlikowski, S M ^a   Leung, R S ^b,c   Tisler, A ^a   Floras, J S ^a   Bradley, T D ^b,c,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cardiovascular physiology; Respiratory physiology; Sleep physiology

Indexed keywords

DIURETIC AGENT;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MALE; POSITIVE END EXPIRATORY PRESSURE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SLEEP PATTERN; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DIASTOLE; FEMALE; HUMANS; HYPERTENSION; MALE; MONITORING, AMBULATORY; POSITIVE-PRESSURE RESPIRATION; SLEEP APNEA SYNDROMES; SYSTOLE; TIME FACTORS;

EID: 12244252795     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00035402     Document Type: Article

References (45)

1. Burt VL, Whelton P, Roccela EJ, et al. Prevalence of hypertension in the US adult population: results form the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
2. McAlister FA, Lewanczuk RZ, Teo KK. Resistant hypertension: an overview. Can J Cardiol 1996; 12: 822-828.
3. Setaro JF, Black HR. Refractory hypertension. N Engl J Med 1992; 327: 543-547.
4. Isaksson H, Ostergren J. Prognosis in therapy-resistant hypertension. J Int Med 1994; 236: 643-649.
5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
6. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 14: 1829-1836.
7. Logan AG, Perlikowski SM, Mente A. High prevalence of obstructive sleep apnea in drug resistant hypertension. J Hypertension 2001; 19: 2271-2277.
8. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904.
9. Parati G, DiRienzo M, Bonsignore MR, et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 1997; 15: 1621-1626.
10. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161: 1423-1428.
11. Weichler U, Herres-Mayer B, Mayer J, Weber K, Hoffman R, Peter JH. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 1991; 78: 124-130.
12. Feldman RD, Campbell N, Larochelle P, et al. 1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension. CMAJ 1999; 161: Suppl. 12, S1-S17.
13. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-764.
14. Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: SHEP Cooperative Research Group. Lancet 1997; 351: 1755-1762.
15. SHEP Co-operative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
16. Frohlich ED. Recognition of systolic hypertension for hypertension. Hypertension 2000; 35: 1019-1020.
17. Izzo JL, Levy D, Black HR. Importance of systolic blood pressure in older Americans. Hypertension 2000; 35: 1021-1024,
18. Singer GM, Black HR. How often can HEDIS goals for hypertension control be achieved in a specialist clinic? Am J Hypertens 2000; 13: 111A.
19. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282: 539-546.
20. Faccenda JF, MacKay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344-348.
21. Pepperell JC, Ramdassing-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 3359: 204-210.
22. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure. A placebo trial. Hypertension 2000; 35: 144-147.
23. Wilcox I, Grunstein RR, Hedner JA. Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 1993; 16: 539-544.
24. Suzuki M, Otsuka K, Guilleminault C. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993; 16: 545-549.
25. Mayer J, Backer H, Brandenburg U, Penzel T, Peter JH, Wichert PV. Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology 1991; 79: 84-92.
26. Gifford RW Jr. Resistant hypertension. Introduction and definitions. Hypertension 1988; 11: Suppl. II, 65-66.
27. Pickering TG. Blood pressure measurement and detection of hypertension. Lancet 1994; 344: 31-35.
28. Rechtschaffen A, Kales AA. A manual of standardized terminology, technique and scoring system for sleep stages of human subjects. Los Angeles, UCLA Brain Information Service/Brain Research Institute, 1968.
29. Tkacova R, Dajani HR, Rankin F, Fitzgerald FS, Floras JS, Bradley TD. Continuous positive airway pressure improves baroreflex sensitivity in patients with obstructive sleep apnea and heart failure. J Hypertens 2000; 18: 1257-1262.
30. Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998; 98: 2269-2275.
31. Chada TS, Watson H, Birch S, et al. Validation of respiratory inductive plethysmography using different calibration procedures. Am Rev Respir Dis 1982; 125: 644-649.
32. Bertinieri G, di Rienzo M, Cavalazzi A, Ferrari AU, Pedotti A, Mancia G. A new approach to analysis of the arterial baroreflex. J Hypertens 1985; 3: Suppl. 3, S79-S81.
33. Cnnan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med 1997; 16: 2349-2380.
34. Brooks D, Horner R, Kozar LF, Render-Teixeira C, Phillipson E. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest 1997; 99: 106-109.
35. Pickering GW, Sleight P, Smyth HS. The reflex regulation of arterial pressure during sleep in man. J Physiol 1968; 194: 46P-48P.
36. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 1995; 98: 118-128.
37. Carlson JT, Rangemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996; 14: 577-584.
38. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-2610.
39. Rauscher H, Formanek D, Popp W, Zwick H. Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea. Thorax 1993; 48: 529-533.
40. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999; 100: 2332-2335.
41. Dustan HP. 50th anniversary historical article: hypertension. J Am Coll Cardiol 1999; 33: 595-597.
42. Black HR. The paradigm has shifted to systolic blood pressure. Hypertension 1999; 34: 386-387.
43. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
44. Morgan TO, Brunner HR, Aubert JF, Wang Q, Griffiths C, Delbridge L. Cardiac hypertrophy depends upon sleep blood pressure: a study in rats. J Hypertens 2000; 18: 445-451.
45. Pelttari LH, Hietanen EK, Salo TT, Kataja MJ, Kantola IM. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am J Hypertens 1998; 11: 272-279.